Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
暂无分享,去创建一个
[1] A. O’Brien,et al. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7 , 1990, Infection and immunity.
[2] J. Samuel,et al. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants , 1990, Infection and immunity.
[3] S. Ostroff,et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.
[4] M. P. Jackson,et al. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity , 1989, Infection and immunity.
[5] H. Mantsch,et al. Interaction of Shigella toxin with globotriaosyl ceramide receptor-containing membranes: a fluorescence study. , 1989, Biochemical and biophysical research communications.
[6] T. Barrett,et al. Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. , 1989, The Journal of infectious diseases.
[7] M. Kyogashima,et al. Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine. , 1989, Archives of biochemistry and biophysics.
[8] S. Saxena,et al. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. , 1989, The Journal of biological chemistry.
[9] C. Lingwood,et al. Verotoxin receptor glycolipid in human renal tissue. , 1989, Nephron.
[10] L. Pickering,et al. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. , 1988, The Journal of pediatrics.
[11] L. Becker,et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.
[12] M. P. Jackson,et al. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine , 1988, Journal of bacteriology.
[13] J. H. Green,et al. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies , 1988, Infection and immunity.
[14] C. Lingwood,et al. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. , 1988, Biochemical and biophysical research communications.
[15] L. M. Sung,et al. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1 , 1988, Journal of bacteriology.
[16] R. Holmes,et al. Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli , 1988, Infection and immunity.
[17] T. Yutsudo,et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.
[18] N. Strockbine,et al. Cloning of genes for production of Escherichia coli Shiga-like toxin type II , 1987, Infection and immunity.
[19] M. P. Jackson,et al. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933 , 1987 .
[20] C. Lingwood,et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.
[21] J. Brown,et al. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. , 1987, The Journal of biological chemistry.
[22] M. Levine,et al. A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells , 1987, Infection and immunity.
[23] J. Wells,et al. Production of Shiga-like toxin by Escherichia coli. , 1986, The Journal of infectious diseases.
[24] R. Holmes,et al. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities , 1986, Infection and immunity.
[25] G. Keusch,et al. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide , 1986, The Journal of experimental medicine.
[26] C. Pai,et al. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli , 1986, Infection and immunity.
[27] R. Holmes,et al. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli , 1985, Infection and immunity.
[28] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[29] R. Holmes,et al. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. , 1984, Science.
[30] L. Enquist,et al. Experiments With Gene Fusions , 1984 .
[31] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[32] S. Gorbach,et al. PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS , 1983, The Lancet.
[33] J. Wells,et al. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype , 1983, Journal of clinical microbiology.
[34] J. Wells,et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. , 1983, The New England journal of medicine.
[35] S. Formal,et al. ESCHERICHIA COLI 0157:H7 STRAINS ASSOCIATED WITH HAEMORRHAGIC COLITIS IN THE UNITED STATES PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA) LIKE CYTOTOXIN , 1983, The Lancet.
[36] V. Cabelli,et al. The effect of plasmid gene expression on the colonizing ability of E. coli HS in mice. , 1982, Recombinant DNA technical bulletin.
[37] F. Bolivar,et al. Construction and characterization of new cloning vehicles. VI. Plasmid pBR329, a new derivative of pBR328 lacking the 482-base-pair inverted duplication. , 1982, Gene.
[38] R. Yu,et al. Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.
[39] J. Magnani,et al. Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. , 1980, Analytical biochemistry.
[40] D. Griffin,et al. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography , 1980, Infection and immunity.
[41] J. Dalrymple,et al. Quantitative microtiter cytotoxicity assay for Shigella toxin , 1980, Journal of clinical microbiology.
[42] Y. Hirota,et al. On the process of cellular division in Escherichia coli: a mutant of E. coli lacking a murein-lipoprotein. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[43] Recombinant DNA Research Guidelines. , 1976, Federal register.